Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Sales (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Return on Sales for 6 consecutive years, with 25.63% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 7856.0% year-over-year to 25.63%, compared with a TTM value of 25.63% through Sep 2025, up 3222.0%, and an annual FY2025 reading of 12.84%, changed N/A over the prior year.
  • Return on Sales was 25.63% for Q3 2025 at Roivant Sciences, up from 5.76% in the prior quarter.
  • Across five years, Return on Sales topped out at 36.26% in Q4 2024 and bottomed at 81.91% in Q2 2022.
  • Average Return on Sales over 5 years is 13.9%, with a median of 8.14% recorded in 2021.
  • The sharpest move saw Return on Sales crashed -6885bps in 2022, then soared 7856bps in 2025.
  • Year by year, Return on Sales stood at 6.64% in 2021, then plummeted by -240bps to 22.57% in 2022, then skyrocketed by 93bps to 1.58% in 2023, then skyrocketed by 2402bps to 36.26% in 2024, then fell by -29bps to 25.63% in 2025.
  • Business Quant data shows Return on Sales for ROIV at 25.63% in Q3 2025, 5.76% in Q2 2025, and 2.73% in Q1 2025.